White et al. argue that scientific, cultural and legal evidence clearly distinguishes coca from cocaine — and that global drug policy must correct this long-standing misclassification rooted in colonial bias.
This dialogue at SOAS explores the coca leaf beyond prohibition — as a bridge between Indigenous knowledge, environmental justice, and drug policy reform. Featuring voices from Colombia and beyond.
The Human Rights Council’s latest resolution on drug policy marks a turning point, reaffirming that drug control is a human-rights issue, and calling for person-centred, inclusive, and accountable approaches.
The upcoming critical review process offers a chance to de-schedule the coca leaf, mitigating prohibition's environmental and social harms, affirming Indigenous rights, and reforming colonial, punitive drug policies.
This publication offers contributions to the debate on land use and climate justice, shining a light on the dynamics arising from current drug policies in Brazil.
Health Poverty Action proposes restructuring illegal trades to prioritise public health, equity, and sustainability rather than reproducing harmful market practices.
Thomson et al. examine coca, opium poppy and cannabis cultivation through the lens of agrarian political economy, drawing attention to key challenges for cultivators posed by synthetics and policy.
IDPC, Viso Mutop and GDPO explore the report's discussion of buoyant drug markets and UNODC's stance on key issues like decriminalisation, human rights and environmental impact, noting the growing influence of green criminology and its potential to reshape perspectives.
Rhodes. et al. shine a light on the criminalised coca trade through the lens of ‘ecological harm reduction’, inviting reflection on practices of care for humans, other living things, and environments, in contexts of structural violence.
The International Coalition on Drug Policy Reform and Environmental Justice shines a light on how global drug prohibition fuels organised crime, corruption and environmental devastation, and calls for closer collaboration between environmental and drug policy movements.
